Notes in Week 6 - DM Pharm

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/11/2025	Metformin has a greater effect in reducing {{c1::fasting::fasting/post-prandial}} glucose
Published	02/11/2025	Metformin should be stopped when eGFR levels are {{c1::< 30}}
Published	02/11/2025	Does metformin cause hypoglycemia?{{c1::No}}
Published	02/11/2025	Glitazones should be avoided in patients with {{c1::hepatic}} impairment
Published	02/11/2025	{{c1::1st}}-generation sulfonylureas have a higher risk of hypoglycemia
Published	02/11/2025	Which 2nd-generation sulfonylurea is contraindicated in treating diabetes due to its long half-life and renal metabolism…
Published	02/11/2025	{{c1::Meglitinides::Meglitinides/Sulfonylureas}} have a faster onset of action and shorter duration of action
Published	02/11/2025	{{c1::Meglitinides::Meglitinides/Sulfonylureas}} should be taken within 30 minutes after eating due to increased risk of hypoglyce…
Published	02/11/2025	DPP-4 inhibitors are more potent when taken {{c1::orally}}
Published	02/11/2025	{{c1::Linagliptin}} is a DPP-4 inhibitor that is not metabolized by the kidney
Published	02/11/2025	GLP-1 agonists should be avoided in patients with {{c1::renal}} impairment
Published	02/11/2025	{{c2::GLP-1 agonists}} are contraindicated in patients with a family history of {{c1::medullary thyroid cancer (MTC…
Published	02/11/2025	GLP-1 agonists are more potent when taken {{c1::intravenously}}
Published	02/11/2025	{{c1::GLP-1 agonists::DPP-4 inhibitors/GLP-1 agonists}} have a higher risk of GI side effects
Published	02/11/2025	SGLT-2 inhibitors lower the renal {{c1::glucose threshold}}
Published	02/11/2025	SGLT-2 inhibitors have a risk of causing {{c1::euglycemic diabetic ketoacidosis}}, especially in patients with type 1 diabetes
Published	02/11/2025	Treatment of hypoglycemia caused by α-glucosidase inhibitors involves administering {{c1::monosaccharides (e.g. glucose)}}
Published	02/11/2025	D2-receptor agonists (e.g. bromocriptine) can be used to treat diabetes by decreasing {{c1::appetite}}
Published	02/11/2025	One adverse effect associated with D2-receptor agonists is {{c1::orthostatic hypotension}}
Published	02/11/2025	To provide basal insulin coverage, use {{c1::long}}-acting insulin analogs
Published	02/11/2025	To provide prandial insulin coverage, use {{c1::short or rapid}}-acting insulin analogs
Published	02/11/2025	{{c1::Pre-mixed}} insulin can be given to patients who need to increase medication adherence
Published	02/11/2025	{{c1::Concentrated}} insulin can be given to patients who require high volumes of insulin
Published	02/11/2025	Using the 15-15 rule, hypoglycemia treatment involves administering {{c1::15g of sugar}} then rechecking blood glucose levels after&nbs…
Published	02/11/2025	{{c1::NPH}} is the only insulin with a cloudy appearance
Status	Last Update	Fields